Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Inflazome synthesizes new NLRP3 inflammasome inhibitors

March 15, 2021

Hunan Warrant Pharmaceuticals patents Bcr-Abl1 and/or BTK inhibitors

March 15, 2021

Targeting membrane protein starves pancreatic tumors

March 15, 2021

Genfleet Therapeutics presents GTPase KRAS mutant inhibitors

March 12, 2021

BeiGene discloses MAP4K1 inhibitors

March 12, 2021

Enrollment opens in phase III trial of [177Lu]PNT-2002 for metastatic CRPC

March 12, 2021

FDA approves Fotivda for relapsed or refractory advanced RCC

March 11, 2021

Dosing initiates in first-in-human study of IMP-7068 in advanced solid tumors

March 11, 2021

Novartis identifies new NSD2 inhibitors

March 11, 2021

Bristol Myers Squibb discloses new IRAK-4 inhibitors

March 11, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...